Namely, Soydinc et al. measured the serum IL-18 levels in 46 patients with aggressive B-cell NHL (DLBCL and grade III follicular lymphoma) before and after chemotherapy, also using 20 healthy individuals as a control group. The gene discussed is IL18; the disease is B-cell non-Hodgkin lymphoma.